22.02.2013 14:35 Uhr, Quelle: Wallstreet online
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
MUMBAI, India and BALTIMORE, February 22, 2013 /PRNewswire/ Approval to add to growing SUPRAX(R) Franchise Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received …
Weiterlesen bei Wallstreet online
JustMac.info